Rotarix vaccine oral syringe 1.5ML
Ended Awarded
- Contract number
- SPE2DB25FQ69W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,600
Award facts
- Contract value 100% obligated
- $13,599.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,599.67 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ml) on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical supply agreement running through December 2026 that enables the company to provide a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with extensive experience fulfilling diverse healthcare commodity requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio demonstrates consistent capability in delivering both brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order for Rotarix vaccine represents routine procurement activity under the existing prime vendor relationship, supporting DLA's mission to maintain adequate pharmaceutical inventory for military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FQ69W?
SPE2DB25FQ69W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FQ69W worth?
The government has obligated $13,600 on SPE2DB25FQ69W.
Is contract SPE2DB25FQ69W an order under another contract?
Yes. SPE2DB25FQ69W is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ69W competed?
The extent of competition for SPE2DB25FQ69W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award